| Literature DB >> 27877797 |
Pengyang Wang1, Xin Wang2, Liming Wang2, Xiaoyang Hou3, Wei Liu4, Chunying Chen2.
Abstract
Gold nanoparticles (Au NPs) possess many advantages such as facile synthesis, controllable size and shape, good biocompatibility, and unique optical properties. Au NPs have been widely used in biomedical fields, such as hyperthermia, biocatalysis, imaging, and drug delivery. The broad application range may result in hazards to the environment and human health. Therefore, it is important to predict safety and evaluate therapeutic efficiency of Au NPs. It is necessary to establish proper approaches for the study of toxicity and biomedical effects. In this review, we first focus on the recent progress in biological effects of Au NPs at the molecular and cellular levels, and then introduce key techniques to study the interaction between Au NPs and proteins. Knowledge of the biomedical effects of Au NPs is significant for the rational design of functional nanomaterials and will help predict their safety and potential applications.Entities:
Keywords: biomedical effect; cellular response; cytotoxicity; gold nanoparticles; protein corona
Year: 2015 PMID: 27877797 PMCID: PMC5099834 DOI: 10.1088/1468-6996/16/3/034610
Source DB: PubMed Journal: Sci Technol Adv Mater ISSN: 1468-6996 Impact factor: 8.090
Figure 1.Various kinds of gold nanoparticles. (a) Gold nanobones. (b) Gold nanohoneycombs. Reprinted with permission from [130]. Copyright 2004 American Chemical Society. (c) Mesoporous silica-coated gold nanorods (Au@SiO2). Reprinted with permission from [10]. Copyright 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (d) Gold nanocages. Reprinted with permission from [131]. Copyright 2007, rights managed by Nature Publishing Group. (e) Gold nanorods. Reprinted with permission from [79]. Copyright 2010 Elsevier Ltd. All rights reserved. (f) Gold nanospheres. Reprinted with permission from [132]. Copyright 2013 WILEY-VCH Verlag GmbH & Co. KGaA Weinheim.
Figure 2.(a) Docking density of the modified PEG influencing the amount of protein adsorbed on the surface of Au NPs. PEG-modified density then determines the Au NP amount by macrophage uptake. Reprinted with permission from [80]. Copyright 2012 American Chemical Society. (b) Cellular uptake pathways for NPs: intracellular trafficking processes and possible endocytosis pathways. Reprinted with permission from [42]. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 3.The binding structures of BSA protein to the surface of Au NRs and the influence on cytotoxicity. (a) The adsorption of BSA on Au NRs by Au-S bond, based on XANES. (b) Disulfides of BSA (yellow) binding to the Au (111) surface of AuNRs. BSA is rendered as a cartoon representation with the three domains colored cyan, red, and blue. Inset: zoomed, two disulfide moieties colored yellow on the surface of Au from the green segment. (c) Number of sulfur atoms in contact of an individual BSA on the gold surface accompanying with time based on molecular dynamics simulation. (d) Cytotoxicity of CATB/Au NRs or serum protein adsorbed CATB/Au NRs, determined by LIVE-DEAD assay. Reprinted with permission from [65]. Copyright 2013 American Chemical Society.
Cellular responses induced by different types of Au NP.
| Shape/size | Modification | Cell line | Uptake/location | Behavior/differentiation | Damage/toxicity | Molecules involved | Signal pathway | References |
|---|---|---|---|---|---|---|---|---|
| Rod 55 nm | Serum protein | A549, 16HBE MSC cells | Clathrin-mediated, from lysosome to mitochondria | Morphological change | Selective lysosomal membranes and actin damage | ROS | Mitochondrion-related pathway | [ |
| Sphere 4 nm | PMA layer | HUVECs, C17.2 cells, PC12 cells | Active endocytosis | Cell cycle arrest | Cytoskeleton damage | Focal adhesion kinase, ROS | Actin-mediated pathway | [ |
| Sphere, rod, urchin, 10–80 nm | PEG, CTAB | Microglia neural cells, transgenic mouse | Shape-dependent | N | Autophagy phagocytosis | IL-1 | Pro-inflammatory signals | [ |
| Sphere 5, 10, 20 nm | PAA, PDHA | HL-60, HEK293 THP-1 | N | N | Inflammation | Mac-1, IL-8, TNF- | Mac-1 receptor pathway | [ |
| Sphere 20 nm | Negative charged | MSCs osteoblast cells | Receptor-mediated endocytosis | MSCs toward osteoblast cells | Mechanical stress | p38 | p38 MAPK pathway | [ |
| NPs 20 nm | FBS | MRC-5 human lung fibroblasts | Endosomes, lysosomes | Autophagosome | Oxidative damage | ROS MAP-LC3 | LKB1-AMPK signal pathway | [ |
| Sphere 10, 25, 50 nm | Negatively charged | Normal rat kidney cells | Size-dependent endocytosis | N | Lysosome impairment | LC3, p62 | Autophagic pathway | [ |
| NPs 5, 20, 50, or 100 nm | Unmodified | EOC, A2780, OVCAR5, SKOV3-ip, OSE | Size-dependent endocytosis | Inhibition of tumor growth and metastasis | N | TSG-14, MMP 8, bFGF, TGF- | p38-MAPK pathways, EMT | [ |
| Au NRs | PSS, SiO2 | NG108-15 neuronal cells | N | Differentiation | N | Ca2+ | Ca2+ signal | [ |
| Au NPs 2.7 nm | Tiopronin | MCF-7,HeLa L929, H520 | Endosomes, lysosomes, perinuclear areas | N | Cytotoxicity depends on dose | ROS | N | [ |
| Spherical Au NPs 21 nm | N | Male C57BL/6 mice, | Abdominal fat tissue, liver | N | No cytotoxicity | TNF | Inflammation related | [ |
| A NR | Cetyltrimethylammonim bromide | A549, 16HBE | Mitochondria, lysosome | Metabolic change | Oxidative stress, mitochondria damage | Lactate GSH GSSG | Metabolic pathway | [ |
| Au NRs 62.3 nm | PDDAC, PSS, PEG | MEF-1, MRC-5 | Lysosome | N | Depend on dose and cell types | Bach-1, HO-1, ROS, | HO-1 pathways | [ |
| Au NPs | PEG-silane layer, cRGD, PEG-diacrylate (PEG-DA) hydrogels | Hematopoietic KG-1a, REF52 | N | Cell adhesion | Affect cell behavior | N | N | [ |
| Au NPs | Single citrate capped | A549 | Lysosome | Cycle arrest at the G0/G1 phase | Aggregation of the MTs, apoptosis | Bax, p53, Bcl-2, PARP | Apoptosis-related pathway | [ |
N: not mentioned. EOC: epithelial ovarian cancer. OSE: ovarian surface epithelial. A549: human alveolar adenocarcinoma epithelial cells. 16HBE: normal bronchial epithelial cells. MEF-1: mouse embryo fibroblast cell line. MRC-5: human embryonal lung fibroblast cell line. REF52: rat embryonic fibroblast. PDDAC: poly (diallyldimethyl ammonium chloride). PSS: polyethylene glycol and polystyrene sulfonate. HO-1: heme oxygenase-1. MTs: microtubules. PARP: poly (ADP-ribose) polymer. MSCs: mesenchymal stem cells. PMA: a phorbol 12-myristate 13-acetate.
Figure 4.(a) TEM image of Au@SiO2 nanocarrier. (b) Influence of photothermal approach on cell sensitivity to DOX by a 780 nm fs-pulse laser irradiation at 3.2 W cm−2 for 12 min. Before NIR irradiation, MCF-7/ADR cells were exposed to 30 μg mL−1 Au@SiO2 in cell culture medium for 24 h. (c) Mechanisms of the reversal of drug resistance of cancer cells under fs-pulse laser irradiation. Photothermal stimulus triggers the activation of heat shock factor (HSF-1) to depress NF-κB pathway that dominates in the regulation in the characteristics of drug resistance. As a result, NIR irradiation modulates cell-signaling pathways to increase the sensitivity of MCF-7/ADR to doxorubicin (DOX) as well as to enhance the DOX accumulation. Reprinted with permission from [114]. Copyright 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 5.(a)–(c) Influence of serum protein-coated CTAB/Au NRs on the lysosomal membrane permeation by AO assay and the mitochondrial membrane potentials by JC-1 assay after they are exposed to 16HBE normal cells and A549 cancer cells. Reprinted with permission from [31]. Copyright 2011 American Chemical Society. (d) Schematic of metabolic responses of A549 and 16HBE cells when they are exposed to serum protein-coated CTAB/Au NRs, metabolites in red or blue indicate remarkable change in its level. Reprinted with permission from [113]. Copyright 2013 Elsevier Ltd. All rights reserved.